Their investigation demonstrated a statistically significant association among FMISO uptake, vascular endothelial growth factor, and Ki-67 immunoreactivity suggesting that glioma hypoxia is biologically associated with angiogenesis and tumor cellular proliferation prior to therapeutic intervention. The gene discussed is VEGFA; the disease is central nervous system cancer.